Evaluation of Echinacea for the Common Cold

NCT00032500 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2006-08-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether three Echinacea preparations with different chemical compositions are effective for prevention or treatment of the common cold.

Conditions

  • Common Cold

Interventions

DRUG

Echinacea

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    lead NIH

Principal Investigators

  • Ronald B. Turner, MD · University of Virginia School of Medicine

  • J. David Gangemi, PhD · Clemson University

  • Rudolf Bauer, PhD · Karl-Franzens-Universitaet Graz

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-09-30
Completion
2004-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00032500 on ClinicalTrials.gov